Maintenance or consolidation therapy in advanced ovarian cancer (Q36681874)

15 August 2017

1 reference

title

Maintenance or consolidation therapy in advanced ovarian cancer (English)

1 reference

15 August 2017

1 reference

Pectasides D

1

1 reference

PubMed ID

17164587

15 August 2017

Pectasides E

series ordinal

2

1 reference

15 August 2017

12 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

70

1 reference

15 August 2017

5

1 reference

15 August 2017

315-324

1 reference

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

15 August 2017

1 reference

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

21 January 2018

1 reference

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer

21 January 2018

1 reference

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000097943

1 reference

15 August 2017

1 reference

PubMed ID

17164587